Status:
COMPLETED
Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rotavirus Gastroenteritis
Eligibility:
All Genders
Up to 5 years
Brief Summary
The purpose of this study is to measure the disease burden from RV GE among children less than 5 years of age using hospital surveillance data. In addition, data collected will determine the seasonal ...
Eligibility Criteria
Inclusion
- A male or female child \< 5 years of age at the time of the visit (a child becomes ineligible on the day of her/his 5th birthday).
- Child is brought to the emergency room for acute GE during the study period or develop acute GE at least 48 hours after hospitalisation.
- Written informed consent obtained from the parent/guardian of the subject.
- Children with RV positive stool sample will be enrolled in the study.
Exclusion
- • Not applicable.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT00751686
Start Date
July 1 2008
End Date
March 1 2010
Last Update
February 18 2013
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Athens, Greece, 104 46
2
GSK Investigational Site
Athens, Greece, 11527
3
GSK Investigational Site
Heraklion, Crete, Greece, 71409
4
GSK Investigational Site
Rio/Patras, Greece, 26500